English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 21 September 2023, 14:29 HKT/SGT
Share:
        

Source: Platohealth.ai / ClinicalSquared
Clinical Squared and PlatoHealth Join Forces to Revolutionize Healthcare with Advanced Data Orchestration Powered by AI

Clinical Squared (C2) and Platohealth.ai are delighted to announce a groundbreaking partnership that promises to reshape the healthcare landscape. Their collaboration brings together the healthcare expertise of C2 and the cutting-edge AI and machine learning capabilities of Plato.ai to create innovative solutions.

Clinical Squared, a leader in healthcare market expertise, data architecture, software development, consultation and implementation services, will lend its extensive industry knowledge to Plato.ai's platform. In turn, Plato.ai will provide advanced AI and machine learning mechanisms to enhance C2's products and services.

This strategic partnership aims to deliver more efficient and effective healthcare solutions for consumers, organizations and the broader healthcare ecosystem.

Marquis Allen, CEO of C2

"We are thrilled to partner with PlatoHealth.ai in our mission to transform healthcare experiences and outcomes using cutting-edge technology. Our collaboration represents a significant milestone for Clinical Squared as we leverage Plato.ai's superior AI capabilities to power our data navigation and orchestration tools for consumers and enterprises in the healthcare sector."

Bryan Feinberg, CEO of PlatoHealth

"This announcement comes at an opportune moment for both companies and we are excited to join forces with Clinical Squared to create transformative healthcare solutions powered by AI and machine learning. This partnership underscores our commitment to improving patient outcomes and healthcare processes. We look forward to the exciting innovations that will emerge from this collaboration."

Key Highlights of the Partnership:

Healthcare Expertise: Clinical Squared's deep healthcare domain expertise will enrich Plato.ai's AI models, ensuring that they are tailored to the specific needs of the healthcare industry.

Advanced AI: Plato.ai's advanced AI and machine learning mechanisms will be integrated into C2 products, enhancing their capabilities for healthcare organizations and technology users of varying skill levels

Innovation: The partnership aims to drive innovation in healthcare by developing solutions that provide security and portability of data as well as deep analytical context for users of the products they collaborate on.

Enhanced Patient Outcomes: By combining industry knowledge with AI-driven insights, the collaboration seeks to contribute to better patient outcomes and overall healthcare quality.

This partnership represents a significant step forward in the quest to harness the power of technology for the betterment of healthcare. Together, Clinical Squared and Plato.ai are committed to creating solutions that address the unique challenges of the healthcare industry, improving efficiency, and ultimately delivering better care to patients.

For more information about Clinical Squared and PlatoHealth.AI, please visit their respective websites:
Clinical Squared: https://www.clinicalsquared.com/about-us/
Plato.ai: https://Platohealth.ai

Contacts:

Bryan Feinberg
CEO, Plato Technologies Inc.
Zephyr@platodata.io

Marquis Allen
CEO, Clincial Squared
marquis.allen@clinicalsquared.com



Topic: Press release summary
Source: Platohealth.ai / ClinicalSquared

Sectors: Artificial Intel [AI], MedTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten  
Dec 12, 2025 14:35 HKT/SGT
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition  
Friday, December 12, 2025 10:00:00 AM
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion  
Thursday, December 11, 2025 10:15:00 PM
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China  
Dec 11, 2025 20:00 HKT/SGT
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing  
Dec 11, 2025 18:09 HKT/SGT
Nasdaq Verafin Joins Global Anti-Scam Alliance  
Dec 11, 2025 14:21 HKT/SGT
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards  
Dec 11, 2025 12:54 HKT/SGT
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating  
Dec 11, 2025 08:20 HKT/SGT
Indonesian Government's Swift Response in Recovering Flood-hit Sumatra  
Dec 10, 2025 23:30 HKT/SGT
TIS Helps Treasury Teams Navigate the Ongoing ISO 20022 Transition After the 2025 Banking Deadline  
Dec 10, 2025 21:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575